Abstract-Catalytic asymmetric syntheses of (-)-centrolobine and (-)-de-O-methylcentrolobine have been achieved, incorporating a hetero-Diels-Alder (HDA) reaction between 4-aryl-2-silyloxy-1,3-butadienes and phenylpropargyl aldehyde derivatives as a key step. The HDA reaction using dirhodium(II) tetrakis[(R)-3-(benzene-fused-phthalimido)-2-piperidinonate], Rh 2 (R-BPTPI) 4 , as a chiral Lewis acid catalyst provides exclusively cis-2,6-disubstituted tetrahydropyran-4-ones in up to 93% ee.
Introduction 1*
Diarylheptanoid natural products containing a tetrahydropyran ring, such as centrolobine, 1 de-Omethylcentrolobine, 1c,2 calyxins 3 and diospongins, 4 exhibit a wide range of biological activity. Not surprisingly, therefore, these compounds have aroused considerable interest within the medicinal and synthetic chemistry communities. [5] [6] [7] (-)-Centrolobine (1) is an antibiotic isolated from the heartwood of Centrolobium robustum and from the stem of Brosinum potabile in the amazon rain forest.
1 (-)-De-Omethylcentrolobine (2), isolated from the same heartwood of Centrolobium robustum, displays a good antileishmanial activity.
1c,2 Solladie and co-workers accomplished the first asymmetric total synthesis of (-)-centrolobine (1) in 2002, ---Since then, a number of groups have achieved the synthesis of 1 in both racemic 9 and optically active forms. 10 A variety of approaches starting with optically active building blocks, obtained by well-established asymmetric reactions or the chiral pool method, have been devised to provide access to the cis-2, 6- and FeCl 3 -mediated cyclization of 1, 5-diol. 10j The hetero-Diels-Alder (HDA) reaction 11 between dienes and carbonyl compounds is one of the most straightforward methods for constructing tetrahydropyran derivatives, because of setting up to three new stereocenters in a single step. Jacobsen and co-workers recently developed highly enantio-and diastereoselective HDA reactions between monooxygenated 1,3-dienes and simple aldehydes catalyzed by tridentate Schiff base Cr(III) complexes. 12 The Jacobsen catalytic asymmetric HDA reaction has found numerous applications in total syntheses of tetrahydropyran-containing natural products. 13 However, the HDA reaction has not yet been adapted to the diarylheptanoid tetrahydropyran system. 14 We recently reported that dirhodium(II) tetrakis[(S)-3-(benzene-fusedphthalimido)-2-piperidinonate], Rh 2 (S-BPTPI) 4 , is a highly efficient Lewis acid catalyst for endo-and enantioselective HDA reactions of a diverse range of aldehydes with Danishefsky-type dienes as well as with monooxygenated dienes, in which up to 99% ee and turnover numbers as high as 48,000 are achieved (Eq. 1). 15, 16 In order to demonstrate the utility of this catalytic methodology, we now addressed asymmetric syntheses of (-)-centrolobine (1) and (-)-de-O-methylcentrolobine (2), focusing on the Rh 2 (R-BPTPI) 4 -catalyzed HDA reaction between 4-aryl-2-silyloxy-1,3-butadienes and phenylpropargyl aldehyde derivatives.
Results and Discussion

Synthetic plan
Our synthetic strategy for 1 and 2 based on the HDA reaction is outlined retrosynthetically in Scheme 1. With the high reactivity of phenylpropargyl aldehyde as a dienophile previously identified, 15 we envisioned that the Rh 2 (R-BPTPI) 4 -catalyzed HDA reaction between 4-aryl-2-triethylsilyloxy-1,3-butadienes 4 and phenylpropargyl aldehyde derivatives 5 would provide cis-(2R,6S)-disubstituted tetrahydropyran-4-ones 3 as the key intermediates. The appropriately protected intermediates 3 could be uneventfully transformed into 1 and 2 via catalytic hydrogenation of the triple bond and removal of the carbonyl group. As for this type of HDA reaction, Baldoli and co-workers reported a ZnCl 2 -promoted stereoselective HDA reaction of 4-(2-methoxyphenyl)-2-trimethylsilyloxy-1,3-butadiene with enantiopure 2-chlorobenzaldehydeCr(CO) 3 complex. 17 However, to the best of our knowledge, no examples of an HDA reaction between monooxygenated dienes bearing phenyl groups at C4 and aldehydes have been reported. 18 In this respect, Wessjohann and coworkers reported that the BF 3 •OEt 2 -mediated reaction of 2-tert-butyldimethylsilyloxy-1,3-butadiene derivative, which has an aromatic ring conjugated to the diene system, with crotonaldehyde and cinnamaldehyde gave the classical Diels-Alder cycloadducts as the sole products, rather than the expected HDA products. 19 Consequently, the development of the HDA reaction between 4-aryl-2-silyloxy-1,3-butadienes and phenylpropargyl aldehydes has become a challenging objective. Scheme 1. Retrosynthetic analysis of (-)-centrolobine and (-)-de-O-methylcentrolobine.
Preparation of dienes and aldehydes for the HDA reaction
At the outset of our studies, we expected that 4-(4-methoxyphenyl)-2-triethylsilyloxy-1,3-butadiene (4a) and 4-(4-benzyloxyphenyl)-2-triethylsilyloxy-1,3-butadiene (4b) would serve as the diene components for the synthesis of 1 and 2, respectively. The dienes 4a and 4b were prepared by the reaction of readily available α,β-unsaturated ketones 6a 20 and 6b 21 with Et 3 SiOTf in the presence of Et 3 N in CH 2 Cl 2 at 0 °C (Scheme 2). 4-Phenyl-2-triethylsilyloxy-1,3-butadiene (4c) as a model diene was also prepared from benzalacetone (6c) under the same conditions.
Scheme 2. Preparation of dienes 4a-c.
Phenylpropargyl aldehydes 5a and 5b, bearing tertbutyldimethylsilyloxy and methanesulfonyloxy groups at the para position on the benzene ring, were prepared by the Sonogashira coupling 22 of propargyl alcohol with iodophenol derivatives 7a 23 and 7b, 24 and subsequent DessMartin oxidation (Scheme 3). 
Enantioselective HDA reaction
On the basis of our previous work, 15 we initially evaluated the HDA reaction between 4-(4-methoxyphenyl)-2-triethylsilyloxy-1,3-butadiene (4a) (1.5 equiv.) and phenylpropargyl aldehyde (5c) as a model system using 1 mol % of Rh 2 (R-BPTPI) 4 . The reaction in dichloromethane at room temperature proceeded in 48 h, and, after treatment with TBAF, gave the cis-2,6-disubstituted tetrahydropyran-4-one 3a as the sole product in 83% yield with 91% ee (Table 1 , entry 1). The cis stereochemistry of 3a was established by the 1 H NOE between C2-H and C6-H (Figure 1 ). Encouraged by this result, we next examined the reaction with p-tert-butyldimethylsilyloxy-substituted phenylpropargyl aldehyde 5a. However, the introduction of this substituent was found to be detrimental as the reaction did not proceed under the foregoing conditions. Even when 5 mol % of the catalyst was used in refluxing dichloromethane, only 15% yield of 3b was isolated, though perfect cis-selectivity and 87% ee were observed (entry 2). Thus, we were gratified to find that the HDA reaction of 4a with aldehyde 5b bearing a methanesulfonyloxy substituent as the electronwithdrawing group proceeded smoothly to completion within 12 h, and, after desilylation, gave exclusively the cis-2,6-disubstituted tetrahydropyran-4-one 3c for the synthesis of (-)-centrolobine (1) in 87% yield with 93% ee (entry 3). The HDA reaction of p-benzyloxy-substituted diene 4b with aldehyde 5b also worked well, providing tetrahydropyran-4-one 3d for the synthesis of (-)-de-Omethylcentrolobine (2) in 84% yield with 90% ee (entry 4). The absolute stereochemistry of 3c and 3d was established as (2R,6S) by their transformation into 1 and 2, respectively (vide infra). For comparison, the HDA reaction between 4-phenyl-2-triethylsilyloxy-1,3-butadiene (4c) and aldehyde 5b in the presence of Rh 2 (R-BPTPI) 4 was then attempted. However, the reaction did not proceed at all (Eq. 2). These results suggest that the combination of an increase in the HOMO energy of silyloxydienes 4 and a decrease in the LUMO energy of phenylpropargyl aldehydes 5 by means of the para-substitutions on the benzene ring is crucial for the success of this type of HDA reaction. As an alternative approach to cis-2,6-disubstituted tetrahydropyran-4-ones, we finally investigated the HDA reaction between 4-methanesulfonyloxybenzaldehyde (8) and 6-(4-benzyloxyphenyl)-2-triethylsilyloxy-1,3-hexadien-5-yne (9) 25 (Eq. 3). However, no reaction occurred. This observation again indicates that the sterically less-demanding and electron-deficient phenylpropargyl aldehydes are particularly suitable dienophiles for the Rh 2 (R-BPTPI) 4 -catalyzed HDA reaction with monooxygenated dienes.
Syntheses of (-)-centrolobine and (-)-de-Omethylcentrolobine
With the efficient construction of cis-2,6-disubstituted tetrahydropyran-4-ones 3c and 3d realized, the stage was now set for the completion of asymmetric syntheses of (-)-centrolobine (1) and (-)-de-O-methylcentrolobine (2). The synthesis of 1 from tetrahydropyran-4-one 3c is illustrated in Scheme 4. A single recrystallization of 3c with 93% ee from ethanol produced optically pure material, mp 134-135 °C, [α] D 22 -4.95° (c 1.02, CHCl 3 ) in 76% yield. Catalytic hydrogenation of the triple bond provided 10 in 96% yield. Tosylhydrazone formation of ketone 10 with ptoluenesulfonyl hydrazine was followed by reduction with NaBH 3 CN in the presence of p-TsOH to produce tetrahydropyran 12 in 75% yield. 27 Finally, removal of the methanesulfonyl group with K 2 CO 3 in MeOH completed the asymmetric synthesis of (-)-centrolobine (1) Consequently, the stereochemical outcome of the present HDA reaction can be rationalized on the basis of the absolute stereochemical model we previously proposed, 15 which contains a hydrogen bond between the formyl hydrogen atom and the carboxamidate oxygen atom 28 in rhodium catalyst-aldehyde complexes ( Figure 2 ). The approach of dienes 4 in an endo mode to avoid intrusion into the rhodium framework leads to the observed cycloadducts 3 with a 2,6-cis-arrangement of substituents. 
Conclusion
We have developed a highly enantio-and diastereoselective HDA reaction between 4-aryl-2-silyloxy-1,3-butadienes and phenylpropargyl aldehyde derivatives using Rh 2 (R-BPTPI) 4 as a chiral Lewis acid catalyst, which provides a straightforward entry to cis-(2R,6S)-2-arylethynyl-6-aryltetrahydropyran-4-ones. This represents the first example of an HDA reaction of 4-aryl-2-silyloxy-1,3-butadienes with aldehydes. Using this catalytic methodology, we have achieved the asymmetric synthesis of (-)-centrolobine in 7 steps and 41% overall yield from 4-iodophenyl methanesulfonate (7b), and the first asymmetric synthesis of (-)-de-O-methylcentrolobine in 8 steps and 39% overall yield from 7b. Further application of this methodology to catalytic asymmetric synthesis of other diarylheptanoid natural products is currently in progress.
Experimental
General
Melting points were determined on a Büchi 535 digital melting point apparatus and are uncorrected. IR spectra were recorded on a JASCO FT/IR-5300 spectrometer and absorbance bands are reported in wavenumber (cm -1 ). 1 H NMR spectra were recorded on JEOL JNM-EX 270 (270 MHz) spectrometer and JEOL JNM-AL 400 (400 MHz) spectrometer. Chemical shifts are reported relative to internal standard (tetramethylsilane; δ H 0.00, CDCl 3 ; δ H 7.26 or acetone-d 6 ; δ H 2.04). Data are presented as follows: chemical shift (δ, ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad), coupling constant and integration.
13 C NMR spectra were recorded on JEOL JNM-AL 400 (100 MHz) spectrometer. The following internal references were used (CDCl 3 ; δ 77.0 or acetone-d 6 ; δ 29.8). Optical rotations were measured on a JASCO P-1030 digital polarimeter at the sodium D line (589 nm). EI-MS spectra were obtained on a JEOL JMSFABmate spectrometer, operating with ionization energy of 70 eV. FAB-MS spectra were obtained on a JEOL JMS-HX 110 spectrometer. 20 (1.5 g, 8.5 mmol) and Et 3 N (2.4 mL, 17 mmol) in CH 2 Cl 2 (20 mL) was added triethylsilyl trifluoromethanesulfonate (1.9 mL, 8.5 mmol) at 0 °C. After stirring at this temperature for 0.5 h, the reaction was quenched with saturated NaHCO 3 solution (10 mL), and the whole was extracted with EtOAc (2×30 mL). The combined organic layers were washed with brine (2×10 mL), and dried over anhydrous Na 2 SO 4 . Filtration and evaporation in vacuo followed by column chromatography (Wakogel ® C-200, 100:1 hexane/EtOAc with 2% Et 3 N) provided 4a (2.17 g, 88%) as a colorless oil: TLC R f = 0.40 (19: 4 mmol) and Et 3 N (5.8 mL, 42 mmol) in CH 2 Cl 2 (15 mL)-DMSO (15 mL) was added sulfur trioxide pyridine complex (3.3 g, 21 mmol) at 0 °C. After stirring at this temperature for 1 h, the mixture was diluted with EtOAc (20 mL), and poured into saturated aqueous NH 4 Cl (20 mL). The whole was extracted with EtOAc (40 mL). The combined organic layers were washed with water (15 mL) and brine (3×15 mL), and dried over anhydrous Na 2 SO 4 
Preparation of dienes
trans-4-(4-Methoxyphenyl)-2-triethylsilyloxy-1,3-butadiene (4a). To a solution of trans-4-(4-
methoxyphenyl)-3-buten-2-one (6a)
trans-6-(4-Benzyloxyphenyl)-3-hexen-5-yn-2-
one. To a solution of (4-benzyloxyphenyl)propynal (1.0 g, 4.2 mmol) in acetone (5 mL) was added 10% aqueous NaOH (5 mL). After stirring at this temperature for 24 h, the reaction mixture was partitioned between EtOAc (30 mL) and water (10 mL). The organic layer was washed with water (5 mL) and brine (2×5 mL), and dried over anhydrous Na 2 SO 4 . Filtration and evaporation in vacuo followed by column chromatography (silica gel, 9:1 hexane/EtOAc) provided the title compound (1.12 g, 96%) as a white solid; mp 100-101 °C; TLC R f = 0.34 (4: 
trans-6-(4-Benzyloxyphenyl)-2-triethylsilyloxy-
Preparation of aldehydes
[4-(tert-Butyldimethylsilyloxy)phenyl]propynal (5a).
To a stirred mixture of (4-tertbutyldimethylsilyloxy)iodobenzene (7a) 23 (2.0 g, 6.0 mmol), copper iodide (11 mg, 0.06 mmol, 1 mol %), PdCl 2 (PPh 3 ) 2 (21 mg, 0.03 mmol, 0.5 mol %), and propargyl alcohol (0.70 mL, 12 mmol) was added Et 3 N (6 mL) at 0 °C. After stirring at 23 °C for 2 h, the reaction mixture was diluted with EtOAc (20 mL), and filtered through a plug of Celite with EtOAc (10 mL). Filtration and concentration in vacuo followed by column chromatography (silica gel, 4:1 hexane/EtOAc) provided 3- [4-(tert- 2H, Ar) . To a solution of 3-[4-(tertbutyldimethylsilyloxy)phenyl]prop-2-yn-1-ol (790 mg, 3.0 mmol) in CH 2 Cl 2 (10 mL) was added Dess-Martin periodinane (1.3 g, 3.0 mmol) at 0 °C. After stirring at this temperature for 3 h, the mixture was poured into an icecooled solution of saturated aqueous NaHCO 3 (5 mL) containing Na 2 S 2 O 3 ·H 2 O (0.5 g). The whole was extracted with EtOAc (50 mL). The combined organic layers were washed with water (2×5 mL) and brine (2×5 mL), and dried over anhydrous Na 2 SO 4 . Filtration and evaporation in vacuo followed by column chromatography (silica gel, 39:1 hexane/EtOAc) provided 5a (760 mg, 97%) as a pale yellow oil: TLC R f = 0.37 (19: 
(4-Methanesulfonyloxyphenyl)propynal (5b).
Following the procedure of Sonogashira coupling of 7a, starting from 4-iodophenyl methanesulfonate (7b) 24 ( Table 1, Entry 3) . To a solution of (4-methanesulfonyloxyphenyl)propynal (5b) (450 mg, 2.0 mmol) in CH 2 Cl 2 (3 mL) was added Rh 2 (R-BPTPI) 4 ·3H 2 O (29 mg, 0.02 mmol, 1 mol %). Then the color of solution changed from pale yellow to brown. After stirring for 5 min, a solution of trans-4-(4-methoxyphenyl)-2-triethylsilyloxy-1,3-butadiene (4a) (870 mg, 3.0 mmol) in CH 2 Cl 2 (1 mL) was added at 23 °C. After stirring at this temperature for 12 h, the reaction mixture turned into deep green solution. The whole mixture was concentrated in vacuo furnished the deep green oil (1.3 g), which was purified by column chromatography (Wakogel ® C-200, 4:1 hexane/EtOAc with 2% Et 3 N) to give silyl enol ether (1.0 g) as a colorless oil. Subsequently, to a solution of the silyl enol ether in THF (4 mL) was added a solution of TBAF in THF (1.0 M, 2.0 mL, 2.0 mmol) at 23 °C. After stirring at this temperature for 0.5 h, the mixture was poured into a two-layer mixture of EtOAc (20 mL) and water (10 mL), and the whole was extracted with EtOAc (40 mL). The organic layer was washed with water (15 mL) and brine (2×15 mL), and dried over anhydrous Na 2 SO 4 . Filtration and evaporation in vacuo furnished the crude product (800 mg) as a pale yellow oil, which was purified by column chromatography (silica gel, 3:2 hexane/EtOAc) to give 3c (700 mg, 87%) as a pale yellow solid: mp 132-133 °C; TLC R f = 0. 25 99. The enantiomeric excess of 3c was determined to be 93% by HPLC with a Chiralpak AD-H column (1:1 hexane/i-PrOH, 1.0 mL/min): t R (major) = 18.2 min for (2R,6S)-enantiomer; t R (minor) = 27.5 min for (2S,6R)-enantiomer. The preferred absolute configuration was establishd as (2R,6S) by transformation of 3c into 1 (vide infra).
Recrystallization was performed by dissolving 3c (700 mg, 1.8 mmol, 93 % ee) in 3 mL of hot EtOH. The pale yellow needles formed at room temperature after standing overnight, and were collected by suction, washed with 1 mL of ice cold EtOH and dried in vacuo to give optically pure 3c (530 mg, 76%); mp 134-135 °C; [α] D 22 -4.95° (c 1.02, CHCl 3 ). The enatiopurity of 3c was determined to be >99% ee by comparison of HPLC retention time with the racemic sample.
4.4.2.
(2R*,6S*)-2-Phenylethynyl-6-(4-methoxyphenyl)tetrahydropyran-4-one (3a) ( Table 1 , Entry 1). According to the typical procedure for HDA reaction, 3a was prepared from diene 4a (130 mg, 0.45 mmol), phenylpropargyl aldehyde (5c) (39 mg, 0.30 mmol), and Rh 2 (R-BPTPI) 4 ·3H 2 O (4.3 mg, 0.003 mmol, 1 mol %) at 23 °C for 48 h. The crude product was purified by column chromatography (silica gel, 3:1 hexane/EtOAc) to provide 3a (76 mg, 83%) as a pale yellow solid: mp 116-117 °C; TLC R f = 0.29 (3:1 hexane/EtOAc); [α] D 23 -8.52° (c 1.02, CHCl 3 ) for 91% ee; IR (KBr) 2233, 1716 cm -1 ; 1 H NMR (400 MHz, CDCl 3 ) δ 2.62-2.92 (m, 4H, CH 2 COCH 2 ), 3.81 (s, 3H, OCH 3 ), 4.66 (dd, J = 2.6, 11.5 Hz, 1H, C6-H), 4.77 (dd, J = 3.0, 11.5 Hz, 1H, C2-H), 2H, Ar), 5H, Ar), 2H, Ar) 5.99 . The enantiomeric excess of 3a was determined to be 91% by HPLC with a Chiralcel OD-H column (9:1 hexane/i-PrOH, 1.0 mL/min): t R = 17.4 min for major enantiomer; t R = 25.7 min for minor enantiomer. In order to assign the stereochemistry at C2 and C6, NOE studies were performed on 3a. Irradiation of C2-H showed NOE with C6-H (15.9%) and C3-H (6.9%). Additionally, irradiation of C6-H exhibited NOE with C2-H (15.8%), C5-H (7.0%) and the ortho proton of the 4-methoxyphenyl group (6.5%). These data revealed cis relationship between C2-H and C6-H. The preferred absolute configuration of 3a was not determined.
4.4.3.
(2R*,6S*)-2-(4-Hydroxyphenylethynyl)-6-(4-methoxyphenyl)tetrahydropyran-4-one (3b) ( Table 1 , Entry 2). According to the typical procedure for HDA reaction, 3b was prepared from diene 4a (130 mg, 0.45 mmol), (4-tert-butyldimethylsilyloxyphenyl) propynal (5a) (78 mg, 0.30 mmol), and Rh 2 (R-BPTPI) 4 ·3H 2 O (22 mg, 0.015 mmol, 5 mol %) at reflux for 48 h. The crude product was purified by column chromatography (silica gel, 2:1 hexane/EtOAc) to provide 3b ( + 322.1205, found 322.1198. The enantiomeric excess of 3b was determined to be 87% by HPLC with a Chiralcel OD-H column (1:1 hexane/i-PrOH, 1.0 mL/min): t R = 7.2 min for major enantiomer; t R = 10.4 min for minor enantiomer. The preferred absolute configuration of 3b was not determined.
(2R,6S)-2-(4-Methanesulfonyloxyphenylethynyl)-6-(4-benzyloxyphenyl)tetrahydropyran-4-one
(3d) (Table 1, Entry 4). According to the typical procedure for HDA reaction, 3d was prepared from diene 4b (550 mg, 1.5 mmol), (4-methanesulfonyloxyphenyl) propynal (5b) (220 mg, 1.0 mmol), and Rh 2 (R-BPTPI) 4 ·3H 2 O (14 mg, 0.01 mmol, 1 mol %). The crude product was purified by column chromatography (silica gel, 3:1 hexane/EtOAc) to provide 3d (400 mg, 84%) as a pale yellow solid: mp 134-135 °C; TLC R f = 0. 4.66 (dd, J = 2.7, 11.3 Hz, 1H, 4.77 (dd, J = 3.2, 11.8 Hz, 1H, C2-H), 5.08 (s, 2H, PhCH 2 O), 2H, Ar), 2H, Ar), 7H, Ar), 2H, Ar) O 6 S: C, 68.05; H, 5.08; S, 6.73. Found: C, 67.84; H, 5.07; S, 6.86 . The enantiomeric excess of 3d was determined to be 90% by HPLC with a Chiralpak AD-H column (1:1 hexane/i-PrOH, 1.0 mL/min): t R (major) = 28.6 min for (2R,6S)-enantiomer; t R (minor) = 39.8 min for (2S,6R)-enantiomer. The preferred absolute configuration was established as (2R,6S) by transformation of 3d into 2 (vide infra).
Recrystallization was performed by dissolving 3d (400 mg, 0.84 mmol, 90 % ee) in 2 mL of hot EtOH. The pale yellow needles formed at room temperature after standing overnight, and were collected by suction, washed with 1 mL of ice cold EtOH and dried in vacuo to give optically pure 3d (290 mg, 73%); mp 135-136 °C; [α] CH 3 CN) . The enatiopurity of 3d was determined to be >99% ee by comparison of HPLC retention time with the racemic sample.
Synthesis of (-)-centrolobine
(2S,6S)-6-[2-(4-Methanesulfonyloxyphenyl)ethyl]-2-(4-methoxyphenyl)tetrahydropyran-4-one (10).
A solution of 3c (200 mg, 0.50 mmol, >99% ee) in EtOAc (10 mL) was stirred with 10% Pd/C (20 mg) 
(2S,6R)-6-[2-(4-Methanesulfonyloxyphenyl)ethyl]-2-(4-methoxyphenyl)tetrahydropyran (12).
To a solution of 10 (170 mg, 0.43 mmol) in MeOH (3 mL) was added TsNHNH 2 (80 mg, 0.43 mmol). The mixture was stirred at reflux for 2 h. After cooling, the solvent was removed in vacuo to give the crude product (260 mg) as a pale yellow solid, which was used without further purification. To a solution of the crude tosylhydrazone (260 mg), TsOH·H 2 O (25 mg, 0.13 mmol) in DMF (3 mL) and sulfolane (3 mL) was added NaBH 3 CN (110 mg, 1.7 mmol) at 23 °C. After stirring at 110 °C for 1 h, the mixture was cooled to room temperature and poured into water (3 mL). The whole was extracted with EtOAc (2×10 mL). The combined organic layers were washed with water (2×5 mL) and brine (2×5 mL), and dried over anhydrous Na 2 SO 4 . Filtration and evaporation in vacuo followed by column chromatography (silica gel, 3:1 hexane/EtOAc) provided 12 (128 mg, 75%) as a white solid: mp 56.5-57.0 °C; TLC R f = 0. 25 
(-)-Centrolobine (1).
To a solution of 12 (110 mg, 0.28 mmol) in MeOH (5 mL) was added K 2 CO 3 (390 mg, 2.8 mmol). The mixture was stirred at reflux for 3 h. After cooling, the reaction mixture was partitioned between EtOAc (10 mL) and water (5 mL). The whole was extracted with EtOAc (2×10 mL). The combined organic layers were washed with water (2×5 mL) and brine (2×5 mL), and dried over anhydrous Na 2 SO 4 3385, 3013, 2936, 2857, 1613, 1514, 1454, 1366, 1304, 1246, 1177, 1078, 1036 (11) . Following the procedure for the preparation of 10, starting from 3d (240 mg, 0.50 mmol, >99% ee) and 10% Pd/C (25 mg), 11 (190 mg, 97%) 
(-)-De-O-methylcentrolobine (2).
Following the procedure for the preparation of 1, starting from 13 (110 mg, 0.29 mmol) and K 2 CO 3 (400 mg, 2.9 mmol), 2 (83.7 mg, 96%) was obtained as a white 4H, Ar), 2H, Ar), 2H, Ar), 8.03 (br, 1H, OH), 8.17 (br, 1H, OH);  13 C NMR (100 MHz, acetone-d 6 ) δ 24.7 (CH 2 ), 31.4 (CH 2 ), 32.0 (CH 2 ), 34.6 (CH 2 ), 39.4 (CH 2 ), 77.6 (CH), 79.8 (CH), 115.5 (CH), 115.8 (CH), 127.8 (CH), 130.1 (CH), 133.9 (C), 135.9 (C), 156.1 (C), 157.1 (C). EI-HRMS m/z calcd for C 19 H 22 O 3 (M) + 298.1569, found 298.1576. The synthetic material 2 was identical in all respects with the reported spectral data for the natural substance (IR, 1 H NMR, 13 C NMR, HRMS), including optical rotation.
